Engineered lactobody-producing lactobacilli: a novel form of therapy against rotavirus infection
H Marcotte, N Pant, L Hammarström - Future Virology, 2008 - Taylor & Francis
Rotavirus infections remain a major cause of morbidity and mortality worldwide, accounting
for an estimated 600,000 deaths each year. New vaccines have been released recently but …
for an estimated 600,000 deaths each year. New vaccines have been released recently but …
[PDF][PDF] Engineered lactobody-producing lactobacilli: a novel form of therapy against rotavirus infection
H Marcotte, N Pant, L Hammarström - Future Virol, 2008 - academia.edu
Engineered lactobody-producing lactobacilli: a novel form of therapy against rotavirus infection
Page 1 part of 10.2217/17460794.3.4.327 © 2008 Future Medicine Ltd ISSN 1746-0794 …
Page 1 part of 10.2217/17460794.3.4.327 © 2008 Future Medicine Ltd ISSN 1746-0794 …
Engineered lactobody-producing lactobacilli: a novel form of therapy against rotavirus infection
H Marcotte, N Pant, L HammarströöM - Future Virology, 2008 - search.proquest.com
Rotavirus infections remain a major cause of morbidity and mortality worldwide, accounting
for an estimated 600,000 deaths each year. New vaccines have been released recently but …
for an estimated 600,000 deaths each year. New vaccines have been released recently but …